Literature DB >> 22313965

Abnormal erythroid cell proliferation and myelofibrosis in a cat.

Tomoko Iwanaga1, Naoki Miura, Noriaki Miyoshi, Yasuyuki Endo, Yasuyuki Momoi.   

Abstract

A cat was presented with severe progressive anemia despite marked erythroblastosis. The cat was negative for feline leukemia virus antigen and feline immunodeficiency virus antibody. Bone marrow cytology revealed an excess of erythroid cells with a predominance of prorubricytes and basophilic rubricytes. No response to immunosuppressive therapy was obtained, and a tentative diagnosis of myelodysplastic syndrome was made. The cat showed a partial response to low-dose cytarabine (20 mg/m(2) subcutaneously q24) but died 51 days after the 1st admission. Histopathological examination revealed fibrosis in the bone marrow and marked infiltration of erythroid cells into other organs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313965     DOI: 10.1292/jvms.11-0268

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

1.  Anti-CD71 antibody immunohistochemistry in the diagnosis of acute myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.

Authors:  Satoshi Suzuki; Naotaka Ogino; Ikki Mitsui; Hiroyuki Ito; Takuro Kariya
Journal:  J Vet Diagn Invest       Date:  2020-11-22       Impact factor: 1.279

2.  Acute myeloid leukemia with basophilic differentiation in a 3-year-old Standardbred gelding.

Authors:  Mary Catherine Furness; Emile Setlakwe; John Sallaway; Darren Wood; Jordan Fromstein; Luis G Arroyo
Journal:  Can Vet J       Date:  2016-10       Impact factor: 1.008

Review 3.  A review of current knowledge of myeloproliferative disorders in the horse.

Authors:  Katy Satué; Juan Carlos Gardon; Ana Muñoz
Journal:  Acta Vet Scand       Date:  2021-02-23       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.